TY - JOUR
T1 - Neurally mediated syncope
T2 - Pathophysiology and implications for treatment
AU - Robertson, Rose Marie
AU - Medina, Eduardo
AU - Shah, Nihal
AU - Furlan, Raffaello
AU - Mosqueda-Garcia, Rogelio
PY - 1999/2
Y1 - 1999/2
N2 - Neurally mediated syncope may occur in patients whose hemodynamic picture does not fit the characteristics of orthostatic intolerance as described elsewhere in this issue. Nonetheless, patients who suffer from neurocardiogenic or vasovagal syncope may be seriously incapacitated by their episodes of syncope or presyncope. Although it has been assumed that vagal activation as a result of stimulation of ventricular mechanoreceptors is essential to the production of these episodes, several critical observations are presented that suggest that other mechanisms may also be operative in some patient subsets. In addition, evidence is presented that the sympathetic responses of many of these patients may be reduced rather than increased and that abnormal baroreflex responsiveness may also play an causative role. These findings suggest new avenues for therapy in this field in which carefully controlled, randomized, double-blind trials are scarce.
AB - Neurally mediated syncope may occur in patients whose hemodynamic picture does not fit the characteristics of orthostatic intolerance as described elsewhere in this issue. Nonetheless, patients who suffer from neurocardiogenic or vasovagal syncope may be seriously incapacitated by their episodes of syncope or presyncope. Although it has been assumed that vagal activation as a result of stimulation of ventricular mechanoreceptors is essential to the production of these episodes, several critical observations are presented that suggest that other mechanisms may also be operative in some patient subsets. In addition, evidence is presented that the sympathetic responses of many of these patients may be reduced rather than increased and that abnormal baroreflex responsiveness may also play an causative role. These findings suggest new avenues for therapy in this field in which carefully controlled, randomized, double-blind trials are scarce.
KW - Baroreflex
KW - Neurocardiogenic
KW - Parasympathetic
KW - Sympathetic
KW - Syncope
UR - http://www.scopus.com/inward/record.url?scp=0032737258&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032737258&partnerID=8YFLogxK
U2 - 10.1097/00000441-199902000-00004
DO - 10.1097/00000441-199902000-00004
M3 - Article
C2 - 10037113
AN - SCOPUS:0032737258
SN - 0002-9629
VL - 317
SP - 102
EP - 109
JO - American Journal of the Medical Sciences
JF - American Journal of the Medical Sciences
IS - 2
ER -